Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04689256 · ClinicalTrials.gov registry record · NA
Pilot Randomized Controlled Study of the Impact of MedRhythms' MR-010 in Acute Stroke
A NA study, sponsored by University of Massachusetts, Worcester.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04689256: Clinical Trial NA study, sponsored by University of Massachusetts, Worcester.
NCT04689256 is a NA study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04689256, a NA study, was terminated before completion, sponsored by University of Massachusetts, Worcester.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this clinical pilot study is to evaluate the effects of the MR-010 on tolerability, biomechanics and walking speed in the acute stroke care setting in addition to its impact on length of stay.
Primary Outcome
Change in gait speed (m/s) from baseline to study completion as measured by a 6 meter walking test.
Interventions
- DEVICE MR-010
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-11-03 |
| Est. Completion | 2023-01-30 |
| Phase | NA |
Why NCT04689256 stopped before completion
NCT04689256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which MR-010 is the first listed.
NCT04689256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04689256 about?
NCT04689256 is a clinical study titled "Pilot Randomized Controlled Study of the Impact of MedRhythms' MR-010 in Acute Stroke". The purpose of this clinical pilot study is to evaluate the effects of the MR-010 on tolerability, biomechanics and walking speed in the acute stroke care setting in addition to its impact on length of stay.
What is the current status of trial NCT04689256?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-11-03. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT04689256?
The interventions under investigation include: MR-010 (DEVICE).
Who is sponsoring clinical trial NCT04689256?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04689256's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI